BRAF and melanoma: EGFR was furthermore reported to mediate resistance to BRAF inhibitors in melanoma [18,19], and the high EGFR expression in colorectal cancer cells is considered to be the reason for the lack of BRAF inhibitor responsiveness of BRAFV600E mutant colorectal cancer [20,21,22].